BEYOND AIR INC XAIR 深 滬
等待開盤 11-26 09:30:00 美东时间
1.34
+0.060
+4.69%
華盛通- 最 高1.345
- 今 開1.27
- 成交量 5.26万股
- 最 低 1.27
- 昨 收 1.28
- 總市值 700.31万
- 52周最高 11.20
- 市盈率 靜 --
- 換手率 1.01%
- 52周最低 1.19
- 委 比 0.00%
- 總股本 522.62万
- 歷史最高 328.20
- 量 比 0.47
- 振 幅 5.86%
- 歷史最低 1.27
- 每 手 1
- 風險率 2.51%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | CoreWeave、Monday遭美银、小摩等多家大行下调目标价；中金首予Nebius "跑赢大市"评级，目标价143美元
今日重点评级关注：Piper Sandler：维持MeiraGTx Hldgs"超配"评级，目标价从28美元升至30美元；RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从26美元升至32美元
11-12 11:43
D. Boral Capital Maintains Buy on Beyond Air, Maintains $11 Price Target
D. Boral Capital analyst Jason Kolbert maintains Beyond Air (NASDAQ:XAIR) with a Buy and maintains $11 price target.
11-11 20:21
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers MSP Recovery (NASDAQ:MSPR) shares rose 93.0% to $0.61 during Tuesday's...
11-11 20:07
Earnings Scheduled For November 10, 2025
Companies Reporting Before The Bell • CBAK Energy Tech (NASDAQ:CBAT) is likely ...
11-10 19:12
Beyond Air Q2 2026 Earnings Preview
Beyond Air (XAIR) is scheduled to announce Q2 earnings results on Monday, November 10th, after market close. The consensus EPS Estimate is -$0.26 (+7.1% Y/Y) and the consensus Revenue Estimate is $2.5...
11-10 06:35
Beyond Air® Secures Up to $32 Million to Accelerate Growth
Beyond Air announced a $32 million financing deal with Streeterville Capital, including a $12 million promissory note and a $20 million equity line of credit. The funds will extend the company's cash runway into 2027 and support commercial expansion, particularly for LungFit PH, aiming to drive sales growth and achieve profitability.
11-05 13:00
Beyond Air to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
Beyond Air, Inc. announced that its CFO, Douglas Larson, will participate in the ROTH 4th Annual Healthcare Opportunities Conference on October 9, 2025, in New York. The company focuses on harnessing nitric oxide (NO) to treat respiratory illnesses, neurological disorders, and solid tumors. Its FDA-approved LungFit PH system is used for neonates with respiratory failure, while other LungFit systems are under clinical trial for severe lung infecti...
09-22 12:00
Beyond Air Announces New Warrant Agreement
Beyond Air ( ($XAIR) ) has shared an update. On September 8, 2025, Beyond Air a...
09-10 01:57
Beyond Air’s NeuroNOS Gains FDA Orphan Drug Status
The latest announcement is out from Beyond Air ( ($XAIR) ). On September 8, 202...
09-09 05:50
Beyond Air Announces Exercise of Warrants for $3.25 Million of Gross Proceeds
Beyond Air, Inc. announced the exercise of 1,439,126 existing common stock warrants at a reduced price of $2.21, generating approximately $3.25 million in gross proceeds. The company will issue 719,561 new warrants exercisable at the same price, with immediate exercise and a five-year term. The offering is expected to close on September 9, 2025, with proceeds to fund clinical programs and operating expenses. The new warrants are being offered in ...
09-08 19:55
